New Zealand markets closed

Royalty Pharma plc (RPRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
37.500.00 (0.00%)
At close: 4:00PM EDT
37.50 0.00 (0.00%)
After hours: 04:32PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 523.31B
Enterprise value 326.48B
Trailing P/E 15.48
Forward P/E 114.97
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)8.61
Price/book (mrq)2.86
Enterprise value/revenue 311.83
Enterprise value/EBITDA 712.47

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-3.28%
S&P500 52-week change 333.64%
52-week high 353.23
52-week low 334.80
50-day moving average 337.17
200-day moving average 340.20

Share statistics

Avg vol (3-month) 32.36M
Avg vol (10-day) 31.29M
Shares outstanding 5427.01M
Implied shares outstanding 6607.17M
Float 8334.98M
% held by insiders 116.42%
% held by institutions 159.07%
Shares short (29 Sep 2021) 48.43M
Short ratio (29 Sep 2021) 42.7
Short % of float (29 Sep 2021) 42.71%
Short % of shares outstanding (29 Sep 2021) 41.97%
Shares short (prior month 30 Aug 2021) 45.88M

Dividends & splits

Forward annual dividend rate 40.68
Forward annual dividend yield 41.81%
Trailing annual dividend rate 30.64
Trailing annual dividend yield 31.71%
5-year average dividend yield 4N/A
Payout ratio 425.81%
Dividend date 314 Sep 2021
Ex-dividend date 417 Nov 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021


Profit margin 43.40%
Operating margin (ttm)83.27%

Management effectiveness

Return on assets (ttm)7.24%
Return on equity (ttm)19.76%

Income statement

Revenue (ttm)2.24B
Revenue per share (ttm)5.62
Quarterly revenue growth (yoy)8.60%
Gross profit (ttm)1.89B
Net income avi to common (ttm)491.78M
Diluted EPS (ttm)1.24
Quarterly earnings growth (yoy)-0.30%

Balance sheet

Total cash (mrq)2.05B
Total cash per share (mrq)4.81
Total debt (mrq)5.83B
Total debt/equity (mrq)55.99
Current ratio (mrq)9.53
Book value per share (mrq)13.43

Cash flow statement

Operating cash flow (ttm)2.13B
Levered free cash flow (ttm)-1.24B